Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
- 7 June 2010
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 19 (8) , 803-807
Abstract
Purpose Women with child wish are advised to take folic acid supplements to reduce the risk for spina bifida. However, there is less evidence for this protective effect in women using valproic acid (VPA). We investigated the effect of folic acid in women exposed to VPA in the first trimester of pregnancy. Methods A case-control study was performed with data from a population-based registry of congenital malformations. Our cases were spina bifida registrations and all other malformed registrations (excluding folic acid sensitive malformations) were used as controls. Results The ORs for the effect of correct folic acid use were calculated among antiepileptic drug (AED) unexposed pregnancies 0.5 [95%CI: 0.3–0.7] and among VPA exposed pregnancies 1.0 [95%CI: 0.1–7.6]. Discussion Due to power-reasons, we cannot conclude that folic acid has no effect on the risk for spina bifida among VPA exposed pregnancies. Although for AED unexposed pregnancies we found a decreased risk. Results from (animal) studies support a biologically plausible association between VPA, folic acid and spina bifida. While folic acid might not be able to reduce the risk for lower spina bifida lesions caused by VPA, the use of folic acid might be important to reduce the risk for higher, folic acid sensitive spina bifida lesions. Further research is needed to get more insight in the most effective form and dose of FA in women that use VPA to reduce the risk for (higher forms of) spina bifida. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy RegisterJournal of Neurology, Neurosurgery & Psychiatry, 2009
- De geschiedenis van de registratie en frequentiebewaking van aangeboren afwijkingen in NederlandTSG - Tijdschrift voor gezondheidswetenschappen, 2008
- Reduction in Neural-Tube Defects after Folic Acid Fortification in CanadaNew England Journal of Medicine, 2007
- Folic acid: a public-health challengeThe Lancet, 2006
- Folic Acid Food Fortification in CanadaNutrition Reviews, 2004
- Letter to the Editor: Folic acid prevents more than neural tube defects: A registry-based study in the northern NetherlandsEuropean Journal of Epidemiology, 2003
- Major malformations in offspring of women with epilepsyNeurology, 2003
- Folic Acid Antagonists during Pregnancy and the Risk of Birth DefectsNew England Journal of Medicine, 2000
- Additional information from parental questionnaires and pharmacy records for registration of birth defectsEuropean Journal of Epidemiology, 2000
- Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproateSeizure: European Journal of Epilepsy, 1999